A pharmaceutically acceptable salt of a condensed polycyclic compound

PK139978AUndetermined Publication Date: 2009-02-20TANABE PHARMA CORP
0 Cites 0 Cited by

Patent Information

Application Number
PK200600750
Authority / Receiving Office
PK · PK
Patent Type
Applications
Current Assignee / Owner
Publication Date
2009-02-20
Patent Text Reader

Abstract

The present invention provides a pharmaceutical salt of novel a condensed polycyclic compound useful as a phosphodiesterase 4 inhibitor, which is shown by the formula [1]: And a pharmaceutical composition containing the same.
Need to check novelty before this filing date? Find Prior Art